|
 The collaboration includes up to $200 million in equity investments,
milestone payments, and research and development services through
2018, Sanofi said in a statement.
MyoKardia was founded in 2012 and is funded by healthcare investor
Third Rock Ventures.
(Reporting by James Regan; Editing by Blaise Robinson)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |
